Dina McGinnis
Pfizer (United States)(US)
Publications by Year
Research Areas
Neuroscience and Neuropharmacology Research, Receptor Mechanisms and Signaling, Cholinesterase and Neurodegenerative Diseases, Phosphodiesterase function and regulation, Pharmacological Receptor Mechanisms and Effects
Most-Cited Works
- → Phosphodiesterase 9A Regulates Central cGMP and Modulates Responses to Cholinergic and Monoaminergic Perturbation In Vivo(2012)79 cited
- → The Discovery and Characterization of the α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Potentiator N -{(3 S ,4 S )-4-[4-(5-Cyano-2-thienyl)phenoxy]tetrahydrofuran-3-yl}propane-2-sulfonamide (PF-04958242)(2015)29 cited
- → Identification of a Potent, Highly Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor Clinical Candidate(2018)27 cited
- → Discovery and Characterization of a Novel Dihydroisoxazole Class of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) Receptor Potentiators(2013)22 cited
- → P4‐197: A selective ORL1 antagonist enhances hippocampal function and reverses pharmacologically induced cognitive deficits in rodents(2011)
- → An investigation of metabotropic glutamate receptor 5 negative allosteric modulators in physiological and behavioral indicators of anxiety and cognition in rodents(2013)
- → CCDC 1402068: Experimental Crystal Structure Determination(2015)